NCT01478763

Brief Summary

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 23, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

September 25, 2014

Status Verified

September 1, 2014

Enrollment Period

3.7 years

First QC Date

November 21, 2011

Last Update Submit

September 24, 2014

Conditions

Proliferative Diabetic Retinopathy

Keywords

PDRPvitreousproteinvitrectomy

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

You may qualify if:

  • proliferative diabetic retinopathy with vitreous hemorrhage

You may not qualify if:

  • vitreous hemorrhage of other cause than proliferative diabetic retinopathy
  • previous vitrectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Erik Eye Hospital

Stockholm, NonUS, 11282, Sweden

Location

Biospecimen

Retention: SAMPLES WITH DNA

Vitreous samples

Study Officials

  • Anders Kvanta, PhD

    St. Erik Eye Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 21, 2011

First Posted

November 23, 2011

Study Start

January 1, 2011

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

September 25, 2014

Record last verified: 2014-09

Locations

SE(1)